Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation

被引：0
|
作者：
Williams, R. [1 ]
Droney, J. M. [1 ]
Nicholson, E. [2 ]
Arias, C. [2 ]
Ellard, R. [2 ]
Bradley, N. [2 ]
Maycock, C. [2 ]
Halley, A. [1 ]
机构：
[1] Royal Marsden Hosp Chelsea, Symptom Control & Palliat Care Dept, London, England
[2] Royal Marsden Hosp Sutton, Haematol, Sutton, Surrey, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.811
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1614P
引用
收藏
页码：S892 / S893
页数：2
相关论文
共 50 条
  • [31] Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy
    Eichenauer, Dennis A.
    Heger, Jan-Michel
    Kruschel, Isabel
    Kutsch, Nadine
    Goedel, Philipp
    Garcia Borrega, Jorge
    Schnetzke, Ulf
    Boell, Boris
    Neumann, Marie Anne-Catherine
    Gebel, Cordula
    Pralong, Anne
    Borchmann, Peter
    Voltz, Raymond
    Wedding, Ulrich
    Simon, Steffen T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 343 - 346
  • [32] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Giulia Bonaldo
    Nicola Montanaro
    Domenico AlbertoVaccheri
    European Journal of Clinical Pharmacology, 2021, 77 : 1225 - 1234
  • [33] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1225 - 1234
  • [34] Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies
    Abbasi, Samane
    Totmaj, Milad Asghari
    Abbasi, Masoumeh
    Hajazimian, Saba
    Goleij, Pouya
    Behroozi, Javad
    Shademan, Behrouz
    Isazadeh, Alireza
    Baradaran, Behzad
    CANCER MEDICINE, 2023, 12 (07): : 7844 - 7858
  • [35] Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
    Kandra, Prameela
    Nandigama, Rajender
    Eul, Bastian
    Huber, Magdalena
    Kobold, Sebastian
    Seeger, Werner
    Grimminger, Friedrich
    Savai, Rajkumar
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] 1-YEAR REVIEW: EVALUATION OF THE PHYSIOTHERAPY PREHABILITATION SERVICE FOR PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) AND CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY
    Evans, Evelyn
    McGoldrick, Bronagh
    Wilson, Keith
    BONE MARROW TRANSPLANTATION, 2024, 59 : 668 - 669
  • [37] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
    Habib, Ali
    Ciurea, Stefan
    Kamboh, Hafsa
    Miljkovic, Milos
    Mozaffar, Tahseen
    NEUROLOGY, 2024, 103 (07) : S119 - S120
  • [38] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [39] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [40] Predictors of Failures following Chimeric Antigen Receptor T-cell (CAR T) Therapy
    Figura, N.
    Jain, M.
    Sim, A.
    Dean, E.
    Balagurunathan, Y.
    Chavez, J.
    Shah, B.
    Khimani, F.
    Lazaryan, A.
    Davila, M.
    Liu, H.
    Kim, S.
    Locke, F.
    Robinson, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S311 - S312
12345